Cargando…

Trypanosomatid-Caused Conditions: State of the Art of Therapeutics and Potential Applications of Lipid-Based Nanocarriers

Trypanosomatid-caused conditions (African trypanosomiasis, Chagas disease, and leishmaniasis) are neglected tropical infectious diseases that mainly affect socioeconomically vulnerable populations. The available therapeutics display substantial limitations, among them limited efficacy, safety issues...

Descripción completa

Detalles Bibliográficos
Autores principales:	Muraca, Giuliana, Berti, Ignacio Rivero, Sbaraglini, María L., Fávaro, Wagner J., Durán, Nelson, Castro, Guillermo R., Talevi, Alan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Chemistry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7726426/ https://www.ncbi.nlm.nih.gov/pubmed/33324615 http://dx.doi.org/10.3389/fchem.2020.601151

Ejemplares similares

Editorial: Lipid Nanoparticles as a Novel Strategy to Deliver Bioactive Molecules
por: Talevi, Alan, et al.
Publicado: (2021)

Nanostructured lipid carriers containing benznidazole: physicochemical, biopharmaceutical and cellular in vitro studies
por: Muraca, Giuliana, et al.
Publicado: (2023)

Novel Phenobarbital-Loaded Nanostructured Lipid Carriers for Epilepsy Treatment: From QbD to In Vivo Evaluation
por: Scioli-Montoto, Sebastian, et al.
Publicado: (2022)

Lipid and fatty acid metabolism in trypanosomatids
por: Parreira de Aquino, Giovana, et al.
Publicado: (2021)

Enzymatic Active Release of Violacein Present in Nanostructured Lipid Carrier by Lipase Encapsulated in 3D-Bioprinted Chitosan-Hydroxypropyl Methylcellulose Matrix With Anticancer Activity
por: Rivero Berti, Ignacio, et al.
Publicado: (2022)

Lipid-Based Nanocarriers for Neurological Disorders: A Review of the State-of-the-Art and Therapeutic Success to Date
por: Witika, Bwalya Angel, et al.
Publicado: (2022)

Autophagy in Trypanosomatids
por: Brennand, Ana, et al.
Publicado: (2012)

Phospholipases A in Trypanosomatids
por: Belaunzarán, María Laura, et al.
Publicado: (2011)

Trypanosomatid protein phosphatases
por: Szöör, Balázs
Publicado: (2010)

Concepts of species in trypanosomatids
por: Momen, Hooman
Publicado: (2003)

The evolution of trypanosomatid taxonomy
por: Kaufer, Alexa, et al.
Publicado: (2017)

Diverse telomeres in trypanosomatids
por: Poláková, Ester, et al.
Publicado: (2021)

Assessment of in vitro cytotoxicity of imidazole ionic liquids and inclusion in targeted drug carriers containing violacein
por: Rivero Berti, Ignacio, et al.
Publicado: (2020)

A comparative study of methylglyoxal metabolism in trypanosomatids
por: Greig, Neil, et al.
Publicado: (2009)

A comparative analysis of trypanosomatid SNARE proteins()
por: Murungi, Edwin, et al.
Publicado: (2014)

Gene Expression in Trypanosomatid Parasites
por: Martínez-Calvillo, Santiago, et al.
Publicado: (2010)

The Limits on Trypanosomatid Morphological Diversity
por: Wheeler, Richard John, et al.
Publicado: (2013)

Genome evolution in trypanosomatid parasites
por: JACKSON, ANDREW P.
Publicado: (2015)

Trypanosomatid parasites in Austrian mosquitoes
por: Schoener, Ellen, et al.
Publicado: (2018)

Lipidomics and anti-trypanosomatid chemotherapy
por: Biagiotti, Michael, et al.
Publicado: (2017)

Transcription Factor Analysis in Trypanosomatids
por: Günzl, Arthur, et al.
Publicado: (2020)

Reproduction in Trypanosomatids: Past and Present
por: Gutiérrez-Corbo, Camino, et al.
Publicado: (2021)

Lipid-Based Nanocarriers for RNA Delivery
por: Xue, Hui Yi, et al.
Publicado: (2015)

Lipid-Based Nanocarriers for The Treatment of Glioblastoma
por: Iturrioz-Rodríguez, Nerea, et al.
Publicado: (2020)

Lipid Nanocarriers for Hyperproliferative Skin Diseases
por: Souto, Eliana B., et al.
Publicado: (2021)

Bioinspired Lipid Nanocarriers for RNA Delivery
por: Golubovic, Alex, et al.
Publicado: (2023)

Ionizable lipids in bio-inspired nanocarriers
por: Zhdanov, Vladimir P.
Publicado: (2023)

Comparative Analysis of Virulence Mechanisms of Trypanosomatids Pathogenic to Humans
por: de Castro Neto, Artur Leonel, et al.
Publicado: (2021)

Mitochondrial Redox Metabolism in Trypanosomatids Is Independent of Tryparedoxin Activity
por: Castro, Helena, et al.
Publicado: (2010)

Inflammatory and Pro-resolving Lipids in Trypanosomatid Infections: A Key to Understanding Parasite Control
por: López-Muñoz, Rodrigo A., et al.
Publicado: (2018)

Nanocarrier System: State-of-the-Art in Oral Delivery of Astaxanthin
por: Abdol Wahab, Nur Rafiqah, et al.
Publicado: (2022)

Solid Lipid Nanoparticles for Drug Delivery: Pharmacological and Biopharmaceutical Aspects
por: Scioli Montoto, Sebastián, et al.
Publicado: (2020)

Double trouble: trypanosomatids with two hosts have lower infection prevalence than single host trypanosomatids
por: Al-Ghafli, Hawra, et al.
Publicado: (2023)

Actin expression in trypanosomatids (Euglenozoa: Kinetoplastea)
por: Souza, Ligia Cristina Kalb, et al.
Publicado: (2013)

Intrinsically disordered proteins (IDPs) in trypanosomatids
por: Ruy, Patrícia de Cássia, et al.
Publicado: (2014)

Phytomonas: Trypanosomatids Adapted to Plant Environments
por: Jaskowska, Eleanor, et al.
Publicado: (2015)

Role of Small RNAs in Trypanosomatid Infections
por: Linhares-Lacerda, Leandra, et al.
Publicado: (2016)

Fresh insights into the pyrimidine metabolism in the trypanosomatids
por: Tiwari, Kartikeya, et al.
Publicado: (2018)

Epigenetic Regulation of Transcription in Trypanosomatid Protozoa
por: Martínez-Calvillo, Santiago, et al.
Publicado: (2018)

Anilinoquinoline based inhibitors of trypanosomatid proliferation
por: Ferrins, Lori, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_79q3lu35264a94d5531rjtgonl